Literature DB >> 12018205

Neutrophil elastase targets virulence factors of enterobacteria.

Yvette Weinrauch1, Doreen Drujan, Steven D Shapiro, Jerrold Weiss, Arturo Zychlinsky.   

Abstract

Shigellae cause bacillary dysentery, a bloody form of diarrhoea that affects almost 200 million people and causes nearly 2 million deaths per year. Shigella invades the colonic mucosa, where it initiates an acute inflammation, rich in neutrophils, that initially contributes to tissue damage and eventually resolves the infection. Neutrophils are phagocytic cells that kill microorganisms but it is unclear how neutrophils control pathogenic bacteria expressing virulence factors that manipulate host cells. In contrast to other cells, neutrophils prevent the escape of Shigella from phagocytic vacuoles in which the bacteria are killed. Here we identify human neutrophil elastase (NE) as a key host defence protein: NE degrades Shigella virulence factors at a 1,000-fold lower concentration than that needed to degrade other bacterial proteins. In neutrophils in which NE is inactivated pharmacologically or genetically, Shigella escapes from phagosomes, increasing bacterial survival. NE also preferentially cleaves virulence factors of Salmonella and Yersinia. These findings establish NE as the first neutrophil factor that targets bacterial virulence proteins.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12018205     DOI: 10.1038/417091a

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  94 in total

1.  Novel ELANE gene mutation in a Korean girl with severe congenital neutropenia.

Authors:  Ye Jee Shim; Hee-Jin Kim; Jang Soo Suh; Kun Soo Lee
Journal:  J Korean Med Sci       Date:  2011-11-29       Impact factor: 2.153

2.  Toxoplasma gondii triggers release of human and mouse neutrophil extracellular traps.

Authors:  Delbert S Abi Abdallah; Changyou Lin; Carissa J Ball; Michael R King; Gerald E Duhamel; Eric Y Denkers
Journal:  Infect Immun       Date:  2011-11-21       Impact factor: 3.441

Review 3.  Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases.

Authors:  Brice Korkmaz; Marshall S Horwitz; Dieter E Jenne; Francis Gauthier
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

4.  Induction of neutrophil extracellular traps by Campylobacter jejuni.

Authors:  Sean Callahan; Ryan S Doster; Joseph W Jackson; Brittni R Kelley; Jennifer A Gaddy; Jeremiah G Johnson
Journal:  Cell Microbiol       Date:  2020-05-21       Impact factor: 3.715

5.  The major human and mouse granzymes are structurally and functionally divergent.

Authors:  Dion Kaiserman; Catherina H Bird; Jiuru Sun; Antony Matthews; Kheng Ung; James C Whisstock; Philip E Thompson; Joseph A Trapani; Phillip I Bird
Journal:  J Cell Biol       Date:  2006-11-20       Impact factor: 10.539

Review 6.  Neutrophil-derived serine proteases in immune complex-mediated diseases.

Authors:  Sofia Z Raptis; Christine T N Pham
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 7.  Neutrophil serine proteases fine-tune the inflammatory response.

Authors:  Christine T N Pham
Journal:  Int J Biochem Cell Biol       Date:  2007-11-29       Impact factor: 5.085

8.  Neutrophil elastase gene polymorphisms: modulators of response to therapy in childhood bronchiectasis?

Authors:  Aleksandra Nikolic; Katarina Milosevic; Srdjan Boskovic; Branimir Nestorovic
Journal:  Lung       Date:  2014-05-11       Impact factor: 2.584

9.  Proteinase 3 and neutrophil elastase enhance inflammation in mice by inactivating antiinflammatory progranulin.

Authors:  Kai Kessenbrock; Leopold Fröhlich; Michael Sixt; Tim Lämmermann; Heiko Pfister; Andrew Bateman; Azzaq Belaaouaj; Johannes Ring; Markus Ollert; Reinhard Fässler; Dieter E Jenne
Journal:  J Clin Invest       Date:  2008-07       Impact factor: 14.808

10.  Mass spectroscopic characteristics of low molecular weight proteins extracted from calcium oxalate stones: preliminary study.

Authors:  Wen-Chi Chen; Chien-Chen Lai; Chein-Cheng Lai; Yuhsin Tsai; Yu-Hsin Tsai; Wei-Yong Lin; Fuu-Jen Tsai
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.